0000835887-13-000118.txt : 20140305 0000835887-13-000118.hdr.sgml : 20140305 20131203131911 ACCESSION NUMBER: 0000835887-13-000118 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20131203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 CORRESP 1 filename1.htm

Progenics Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591
Fax: (914) 789-2817
 (914) 789-2800
 
www.progenics.com



December 3, 2013

 
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549

Attention:  Mr. Jeffrey P. Riedler
 
 
Re:
Progenics Pharmaceuticals, Inc.
 
Form 10-K for the fiscal year ended December 31, 2012
 
Filed March 15, 2013
 
Form 10-Q for the Quarterly Period Ended June 30, 2013
Filed August 9, 2013
File No. 000-23143

Dear Mr. Riedler:
 
We have received your November 19th letter to Mr. Baker conveying additional comments of the SEC Staff on the above-referenced filings in response to our October 18th response letter.  In order to complete the collection and compilation of relevant information, and to prepare responses to the Staff's comments with necessary and appropriate input from Company officers, employees and advisors, Progenics hereby respectfully requests the Staff to grant an extension of an additional ten business days to provide its response.  This extension will permit the Company to respond fully and properly to all of the matters raised in your letter.

Please contact me at (914) 789-2805 or dmartin@progenics.com if you have any questions or require additional information.
 
Sincerely,
 
/s/ David E. Martin

David E. Martin
General Counsel

cc:
Mr. Baker
Bryan J. Pitko, Esq.
Austin Stephenson, Esq.


GRAPHIC 2 image0.jpg begin 644 image0.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#KO&_AZ/P_ MH:WEG>W>\RK'M=@P.?PJ3PSX3_MSP[:W\FK7<3RJ250*5'/TK4^*I_XI)?\` MKX2M+X?8_P"$(T[_`'#_`#-^`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`HJ.#2 MY@P"Q$92E0BGHT[VVZGP%'.C6>$JP<4U>^UK._P!QJ$9[4?A7%GQAK+V;7\7ABX-F%WAF ME`8KZX^E;NC>(;?6-(MM0CBDC6920C6C3_(Y[XJ_\ MBFO_`%\)67X4T#6[WPQ:3VOB2XM('4[840';SZUI?%*5#X555=2_VA.-P_E6 MC\/Y(QX,TY?,3=L/R[ADG&I.GE<7%?;>ZOT\RM8?#RR2]6]U6 M[N-4N%Y!G;Y?RKLE554*H``&`!VI:0D*,D@"MXQ45H>35KU*SO-W/'M5TZ+5 MOBW)8SLXAE<;]AP2`F<5ZG!HVFV[0-%8VZ/`,1LJ`%1[5YLSH/C4'W)LW8SD M8_U?K7JRE6^92"#W!S6-%*\O4]',YS4:*ZGR MC)_6O71@=*\>\5P3^&?B)!K+HWV6259%<#CD88?7K7K5G=V][:IX\TC>E0G#X.7\>IY-XYA.B>/[*_M/W;SE)3CUS@_G6E\7)IVL=, M"Y$#EF(]6QP#5?Q+'_PEOQ%L[&Q(EBLU`GD7[JC.3S^E=%\1+_3;70TL+NV$ M\URP2!2<;#TW$]@*S<=)]COA5Y:N%O'FDEJO+I^&IT/AWR1X5Y"8Q] M.?US7F/AT-'\6IEL_P#4^;*'"]-N.?UKHM,\)>*-/TV.RM/$<26K)D@Q;BA/ M7:?2MWPSX/L_#:22([W%W+_K+B0E:.,I\MU:QQQK4<-&LU/FM2G^]DF[%U8Q_ MLZE*,.9*]]]'\CAUMM4NOB/!J]MI%Y;6[RJ6\Q,8&,-FN\\(Q%'FC:UDM]D_,S/A8JCP@&V@,9WR<T\--&"($X+CTK@/&TL;_$ M71F1U908\D$8'/?>FN)&+N>IP<5L^,=+;6_"MY;6Y#2E=\>#G)7G%<;\-/$UM:VLN MBW\HMY$D+1&4XZ]5/N*6U/9J[4DWWM_D=]KVB6_B#2GL;AV2 M-V#;DZ@@UR?Q-T2\OM%LY+-'E6T8[XTZD8`SCOC%=C=ZOIUC;F>YO8(HU&23 M(*RM<\3KI4^CF-(Y+:_EV-(3C:I'!'YU=11::>AS8*I7IU82@KV;:3VVU_`Y MG0OB1IMQ8II^LQ/;.(_):4#*'C&3W%=EHNDZ=9Z1;P6,K2VR@F-]^<@DGK^- M9/B[PSHMYI%W>SP0P3QQEUN$^4Y`XSZUYOHL?B%M(MVL3-]F()3:2!U.G3PM#&TW4H2]GKJGM?R9Z?)X`\/38,EH[]/O2L?YT^W\"Z#:3)- M!;2(\;!EQ*W!^E=)171[./8\9XS$-6186R1)U)'+,?<]ZXCXF?V?? MR66FH))-79@+=(^P/9O:O1\5Y=XGT[5-&\=Q^(XK26[LP59O+7<5`&"*SJKW M;)'=EDG+$NI*7O)-K7=]%<9%\,=<,:EM>\ML?<#/\OMUK)U6T\5>!)X;G^TV MEA=L!@Y9">ZD'UKT*'Q]H$L09IYHF(_U;PL&'MTKG]?DOO'TEOI^F6,\.G)( M&EN[B,H#[`'DUDZ<.7W-ST:&,Q3J*6GD=4^NV,GAJWU*_A8VUS&N M]-FX`MQ@CZUR>H>'/!N^YN&M[VWD@`>6"(E&"G^(#T]Q6]XKM$T_P2+*`D+$ MT*(<9/##FHM?TEDT?4M4N+@373V@ACVKA57.<#UK22OI)7//P\O9VE3DXJ4F MM'Z?YFKHWA;1='`GLK-1*P!\V3YG/ODT:EX3T?6+MKF]@>21@`?WA`('MTK% MFN9-(O+J-M1O'M38)*#-%TJ[CNK.W:.6,Y7]X61R9>_!!'%4K*\N[>'1;V;4K MIOM4T51W?KY_P"3-7_A7_AT#'V1P/:5O\:0 M_#SPV3DV;$^ID)-89UV^A6\>TFN)$-DDR&1][#+`,^!T..2.U:6IW$EE#:-9 M:E-/:W,R)/(TNX1#!.YM#',>LD+;"Q]_6L])M0L-2TH7>IM);27$J%@^4V;,J M&;N0:J03SW;Z2\]]<;5U"XC,OF[?E^;:"?7&,4W*+5FC*G"M"?M(S:?=7\_\ MC0T;P;X:@NYC':S7$UL^TFZ)<`XS\N>#6WK'A_3==MXX+^WWK$X2T7[/!J5Y*SQRS1;9@%& M`/X^^#T%"<;6L5*.(G.,W)WZ;E>+P?X?76QI:[>" M"*WA2&*-4C0855&`!7"&[NKJXL[E;M(KMM(_US#(#[N].CUR6V3R;A-869"0 9X@(E3.?X6[BE%Q6Q5:A6JM*4KO\`X<__V3\_ ` end